Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-5578

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches ; day:3 ; month:6 ; year:2022 ; pages:1-15
Molecular psychiatry ; (3.6.2022), 1-15

Creator: Mary, Arnaud
Eysert, Fanny
Checler, Frédéric
Chami, Mounia

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41380-022-01631-6

URN: urn:nbn:de:101:1-2022080221213868116964

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Mary, Arnaud
Eysert, Fanny
Checler, Frédéric
Chami, Mounia
SpringerLink (Online service)

Other Objects (12)

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Aufsatzsammlung

Alzheimer disease : therapeutic strategies

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease

Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

Rho GTPases as therapeutic targets in Alzheimer’s disease

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

Therapeutic implications of necroptosis activation in Alzheimer´s disease

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

New approaches to symptomatic treatments for Alzheimer’s disease

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Aufsatzsammlung

Alzheimer disease : therapeutic strategies

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease

Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

Rho GTPases as therapeutic targets in Alzheimer’s disease

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

Therapeutic implications of necroptosis activation in Alzheimer´s disease

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

New approaches to symptomatic treatments for Alzheimer’s disease

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Aufsatzsammlung

Alzheimer disease : therapeutic strategies

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease

Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

Rho GTPases as therapeutic targets in Alzheimer’s disease

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

Therapeutic implications of necroptosis activation in Alzheimer´s disease

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

New approaches to symptomatic treatments for Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Alzheimer disease : therapeutic strategies

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease

Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

Rho GTPases as therapeutic targets in Alzheimer’s disease

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

Therapeutic implications of necroptosis activation in Alzheimer´s disease

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

New approaches to symptomatic treatments for Alzheimer’s disease

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Alzheimer disease : therapeutic strategies

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease

Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

Rho GTPases as therapeutic targets in Alzheimer’s disease

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

Therapeutic implications of necroptosis activation in Alzheimer´s disease

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

New approaches to symptomatic treatments for Alzheimer’s disease

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?

Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease

Alzheimer disease : therapeutic strategies

Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease

Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains

Rho GTPases as therapeutic targets in Alzheimer’s disease

DUBs in Alzheimer’s disease: mechanisms and therapeutic implications

Therapeutic implications of necroptosis activation in Alzheimer´s disease

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

New approaches to symptomatic treatments for Alzheimer’s disease

Related objects

Reset password